Clinical Trials Directory

Trials / Completed

CompletedNCT06354933

Neurological Soft Signs in Neurodegenerative Dementias

Status
Completed
Phase
Study type
Observational
Enrollment
186 (actual)
Sponsor
University of Milano Bicocca · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The goal of this observational study is to investigate the prevalence of Neurological Soft Signs (NSS) in various categories of dementia patients compared to matched controls. The main questions it aims to answer are: * Does the prevalence of NSS significantly differ among patients with neurodegenerative dementias compared to controls? * Are NSS associated with neuropsychiatric alterations in dementia patients? * Do NSS correlate with cognitive screening tools? * Do NSS increase over time in patients with neurodegenerative dementias? Participants will undergo assessments including: * Evaluation of NSS using the Heidelberg scale * Neuropsychiatric assessments * Cognitive screening using the Mini-Mental State Examination (MMSE) and Frontal Assessment Battery (FAB) Researchers will compare dementia groups (Alzheimer's disease, Frontotemporal dementia, Corticobasal syndrome and Lewy body dementia) to controls to determine differences in NSS prevalence. Additionally, associations between NSS and neuropsychiatric symptoms, as well as cognitive performance, will be explored.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTNeurological Soft SignsNeurological Soft Signs score according to the Heidelberg Manual

Timeline

Start date
2022-04-01
Primary completion
2023-11-30
Completion
2024-02-01
First posted
2024-04-09
Last updated
2026-03-25

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06354933. Inclusion in this directory is not an endorsement.